Growth Hormone Deficiency Clinical Trials

8 recruiting

Growth Hormone Deficiency Trials at a Glance

14 actively recruiting trials for growth hormone deficiency are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in Seattle, Minneapolis, and Las Vegas. Lead sponsors running growth hormone deficiency studies include Ascendis Pharma Endocrinology Division A/S, Baylor College of Medicine, and Assistance Publique - Hôpitaux de Paris.

Browse growth hormone deficiency trials by phase

Treatments under study

About Growth Hormone Deficiency Clinical Trials

Looking for clinical trials for Growth Hormone Deficiency? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Growth Hormone Deficiency trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Growth Hormone Deficiency clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.

Isolated Non-acquired Growth Hormone Deficiency
Assistance Publique - Hôpitaux de Paris200 enrolled1 locationNCT07333521
Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Growth Hormone Deficiency
Ascendis Pharma Endocrinology Division A/S900 enrolled27 locationsNCT05820672
Recruiting
Phase 3

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

Growth Hormone Deficiency (GHD)
Lumos Pharma150 enrolled26 locationsNCT06948214
Recruiting
Phase 1

A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

SafetyTolerabilityAdult Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd.64 enrolled1 locationNCT07016802
Recruiting
Phase 3

Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

Mild Traumatic Brain InjuryAdult Growth Hormone Deficiency
VA Office of Research and Development172 enrolled4 locationsNCT04867317
Recruiting
Phase 4

Effects of GH and Lirglutide on AgRP

HealthyGrowth Hormone Deficiency
Columbia University40 enrolled1 locationNCT05681299
Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Growth Hormone Deficiency
Ascendis Pharma Endocrinology Division A/S500 enrolled27 locationsNCT05775523
Recruiting

Chromosome 18 Clinical Research Center

Growth Hormone DeficiencyChromosome AberrationsHypomyelination
The University of Texas Health Science Center at San Antonio4,000 enrolled2 locationsNCT00227253
Recruiting
Phase 2

Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)

Adult Growth Hormone DeficiencyGulf War Syndrome
Baylor College of Medicine20 enrolled2 locationsNCT05355272
Recruiting

Neuropsychological Assessment of Children and Adolescents With Turner Syndrome

Social CognitionPediatricsCognitive Functions+2 more
University Hospital, Angers70 enrolled3 locationsNCT03812913
Recruiting
Not Applicable

Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH

Growth Hormone Deficiency
Cliniques universitaires Saint-Luc- Université Catholique de Louvain500 enrolled1 locationNCT06542809
Recruiting

Use of miRNAs in Growth Hormone Deficiency (GHD)

Growth Hormone Deficiency
University of Parma400 enrolled1 locationNCT06455956
Recruiting

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

Turner SyndromeGrowth Hormone DeficiencySmall for Gestational Age+1 more
Dong-A ST Co., Ltd.2,500 enrolled1 locationNCT04798690
Recruiting

Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

Turner SyndromeChronic Renal FailureGrowth Hormone Deficiency+2 more
LG Chem6,000 enrolled1 locationNCT01604395